SPY420.86+5.94 1.43%
DIA338.78+5.82 1.75%
IXIC14,141.48+111.10 0.79%

Ocugen Shares Ticking Higher; Co Vaccine Partner Bharat Biotech's COVID-19 Vaccine Covaxin Recommended By Expert Panel For Phase II/III Clinical Trials On 2 To 18 Year-Olds

-Reuters

05/11/2021 15:24